Safety, pharmacokinetics, and antitumor activity of MEDI3617, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
Ronald B. Natale
Research Funding - MedImmune
Naiyer A. Rizvi
Research Funding - MedImmune
Jeffrey R. Infante
No relevant relationships to disclose
Lindsay J. Joseph
No relevant relationships to disclose
Jaye Viner
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Jennifer T. McDevitt
Employment or Leadership Position - MedImmune
Fei Ji
Employment or Leadership Position - MedImmune
Soyoung Shin
Employment or Leadership Position - MedImmune
Meina Liang
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Howard A. Burris
Research Funding - MedImmune